Inhibition of platelet aggregation: in ischemic heart disease, in acute myocardial infarction or suspected acute myocardial infarction, in the prevention of thromboembolic complications after coronary artery bypass graft (CABG), after percutaneous coronary intravascular angioplasty (PTCA), in the prevention of transient ischemic attacks. TIA) and ischemic stroke in patients with TIA, to prevent first myocardial infarction in patients with multiple risk factors, to prevent deep vein thrombosis in long-term immobilized patients, e.g. following major surgery as an adjunct to other prophylaxis.
The medicinal product must not be used: in case of hypersensitivity to the active substance, other salicylates or to any of the excipients, in patients with hemorrhagic diathesis, with active gastric and / or duodenal ulcer disease, with severe renal failure, severe liver failure, severe heart failure with a history of bronchial asthma attacks caused by the administration of salicylates or substances with a similar effect, especially non-steroidal anti-inflammatory preparations, simultaneously with methotrexate in doses of 15 mg per week or more, in the last trimester of pregnancy, in children up to 12 years of age in the course of viral infections due to the risk of Reye's syndrome - a rare but serious disease that causes damage to the liver and brain.
One gastro-resistant tablet contains 75 mg of acetylsalicylic acid.
There are no reviews for this product.